Rachel Curtis Gravesen

Director/Board Member at CESSATECH A/S

57 year

Health Technology

Consumer Services

Commercial Services

Profile

Rachel Curtis Gravesen formerly worked at Novo Nordisk A, as Communications Manager, Genmab A, as Senior VP-Investor Relations & Communications from 2011 to 2019, and Pharmaceutical Development Center, as Vice President-Investor Relations.
Ms. Gravesen received her undergraduate degree from City University London and graduate degree from the University of Cambridge.

Latest news about Rachel Curtis Gravesen

28/25/28	Cessatech: Minutes from the Annual General Meeting in Cessatech A/S	PU
28/25/28	Minutes from the Annual General Meeting in Cessatech A/S	AQ
12/25/12	Cessatech: Annual General Meeting - 28 March 2025	PU
12/25/12	Annual General Meeting - 28 March 2025	AQ
05/24/05	Cessatech: Cessatech announces changes to the Board of Directors	PU

Rachel Curtis Gravesen active positions

Companies	Position	Start
CESSATECH A/S	Director/Board Member	17/03/2022

All active positions of Rachel Curtis Gravesen

Former positions of Rachel Curtis Gravesen

Companies	Position	End
GENMAB A/S	Investor Relations Contact	11/03/2019
NOVO NORDISK A/S	Public Communications Contact	-
Pharmaceutical Development Center Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products	Public Communications Contact	-

See the detail of Rachel Curtis Gravesen's experience

Training of Rachel Curtis Gravesen

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rachel Curtis Gravesen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Novo Nordisk A/S Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care	Health Technology
Genmab A/S Genmab A/S Pharmaceuticals: MajorHealth Technology Develops differentiated antibody therapeutics for treatment of cancer	Health Technology
University of Cambridge University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pharmaceutical Development Center Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products	Commercial Services
City University London City University London Functions as a College/University
Cessatech A/S Cessatech A/S Develops and commercializes medicines for children for the treatment of pediatric acute pain